Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · IEX Real-Time Price · USD
5.05
-0.28 (-5.25%)
At close: Mar 27, 2024, 4:30 PM
5.21
+0.16 (3.17%)
Pre-market: Mar 28, 2024, 4:05 AM EDT

Intensity Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current20232022202120202019
Market Capitalization
73117----
Enterprise Value
581033-2-9-8
PE Ratio
-9.90-9.90----
PB Ratio
5.558.93----
P/FCF Ratio
-16.31-16.31----
P/OCF Ratio
-16.31-16.31----
EV/EBITDA Ratio
-10.20-10.20-0.410.281.491.54
EV/EBIT Ratio
-10.05-10.05-0.400.281.461.51
EV/FCF Ratio
-14.27-14.27-0.550.321.641.84
Debt / Equity Ratio
0.010.01-0.29-0.27-0.32-0.11
Debt / EBITDA Ratio
-0.01-0.01-0.59-0.30-0.08-0.05
Debt / FCF Ratio
-0.02-0.02-0.79-0.34-0.09-0.06
Quick Ratio
3.733.730.191.226.927.44
Current Ratio
3.913.910.211.277.047.67
Interest Coverage
-33.55-33.55-91.46---
Return on Equity (ROE)
-168.00%-168.00%57.70%138.00%306.60%-
Return on Assets (ROA)
-89.00%-89.00%-338.40%-105.80%-63.20%-
Return on Capital (ROIC)
-62.55%-62.55%70.24%126.37%586.63%268.26%
Earnings Yield
-16.23%-10.10%----
FCF Yield
-9.86%-6.13%----
Buyback Yield / Dilution
-152.67%-152.67%--0.02%-0.19%-
Total Shareholder Return
-152.67%-152.67%--0.02%-0.19%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).